Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer

por Zhu, Wenzhen, Ren, Chongyang, Wang, Yulei, Wen, Lingzhu, Zhang, Guochun, Liao, Ning
Publicado 2020

GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients

por Zhang, Guochun, Qian, Xueke, Ren, Chongyang, Wen, Lingzhu, Lyu, Haitong, Liao, Ning
Publicado 2019

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA

por Li, Xuerui, Chen, Xiaoqing, Wen, Lingzhu, Wang, Yulei, Chen, Bo, Xue, Yunlian, Guo, Liping, Liao, Ning
Publicado 2020

Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer

por Lai, Jianguo, Chen, Bo, Zhang, Guochun, Wang, Yulei, Mok, Hsiaopei, Wen, Lingzhu, Pan, Zihao, Su, Fengxi, Liao, Ning
Publicado 2019

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

por Zhang, Yuchen, Li, Cheukfai, Xia, Chenglai, Wah To, Keneth Kin, Guo, Zhixing, Ren, Chongyang, Wen, Lingzhu, Wang, Fang, Fu, Liwu, Liao, Ning
Publicado 2022

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado 2021

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics

por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado 2021

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis

por Li, Cheukfai, Zhang, Guochun, Wang, Yulei, Chen, Bo, Li, Kai, Cao, Li, Ren, Chongyang, Wen, Lingzhu, Jia, Minghan, Mok, Hsiaopei, Lai, Jianguo, Xiao, Weikai, Li, Xuerui, Liao, Ning
Publicado 2022

Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature

por Li, Cheukfai, Ren, Chongyang, Wen, Lingzhu, Chen, Xiaoqing, Chen, Bo, Zhang, Guochun, Wang, Yulei, Li, Kai, Cao, Li, Jia, Minghan, Mok, Hsiaopei, Lai, Jianguo, Xiao, Weikai, Li, Xuerui, Liao, Ning
Publicado 2022

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing

por Jia, Minghan, Liao, Ning, Chen, Bo, Zhang, Guochun, Wang, Yulei, Li, Xuerui, Cao, Li, Mok, Hsiaopei, Ren, Chongyang, Li, Kai, Li, Cheukfai, Wen, Lingzhu, Lin, Jiali, Wei, Guangnan, Balch, Charles M.
Publicado 2021

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

por Zhang, Guochun, Ren, Chongyang, Li, Cheukfai, Wang, Yulei, Chen, Bo, Wen, Lingzhu, Jia, Minghan, Li, Kai, Mok, Hsiaopei, Cao, Li, Chen, Xiaoqing, Lin, Jiali, Wei, Guangnan, Li, Yingzhi, Zhang, Yuchen, Balch, Charles M., Liao, Ning
Publicado 2022

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients

por Wen, Lingzhu, Zhang, Guochun, Ren, Chongyang, Li, Xuerui, Mok, Hsiaopei, Jia, Minghan, Wang, Yulei, Chen, Bo, Li, Kai, Cao, Li, Li, Cheukfai, Xiao, Weikai, Lai, Jianguo, Lin, Jiali, Wei, Guangnan, Li, Yingzi, Zhang, Yuchen, Chen, Xiaoqing, Liao, Ning
Publicado 2021

Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations

por Li, Kai, Cao, Li, Li, Cheukfai, Wu, Jundong, Chen, Bo, Zhang, Guochun, Li, Xueri, Wen, Lingzhu, Jia, Minghan, Wei, Guangnan, Lin, Jiali, Li, Yingzi, Zhang, Yuchen, Mok, Hsiaopei, Ren, Chongyang, Wang, Yulei, Qi, Xiaofang, Guo, Lijie, Che, Yue, Liao, Ning
Publicado 2022

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer

por Chen, Bo, Zhang, Guochun, Li, Xuerui, Ren, Chongyang, Wang, Yulei, Li, Kai, Mok, Hsiaopei, Cao, Li, Wen, Lingzhu, Jia, Minghan, Li, Cheukfai, Guo, Liping, Wei, Guangnan, Lin, Jiali, Li, Yingzi, Zhang, Yuchen, Han-Zhang, Han, Liu, Jing, Lizaso, Analyn, Liao, Ning
Publicado 2020

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy

por Li, Kai, Liao, Ning, Chen, Bo, Zhang, Guochun, Wang, Yulei, Guo, Liping, Wei, Guangnan, Jia, Minghan, Wen, Lingzhu, Ren, Chongyang, Cao, Li, Mok, Hsiaopei, Li, Cheukfai, Lin, Jiali, Chen, Xiaoqing, Zhang, Zhou, Hou, Ting, Li, Min, Liu, Jing, Balch, Charles M., Liao, Ning
Publicado 2020

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours

por Chen, Bo, Zhang, Guochun, Lai, Jianguo, Xiao, Weikai, Li, Xuerui, Li, Cheukfai, Mok, Hsiaopei, Li, Kai, Wang, Yulei, Cao, Li, Jia, Minghan, Ren, Chongyang, Wen, Lingzhu, Wei, Guangnan, Lin, Jiali, Li, Yingzi, Zhang, Yuchen, Chen, Xiaoqing, Wu, Xueying, Zhang, Henghui, Li, Min, Liu, Jing, Balch, Charles M., Liao, Ning
Publicado 2021